The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
E5531, a Pure Endotoxin Antagonist of High Potency
Abstract
Shock due to Gram-negative bacterial sepsis is a consequence of acute inflammatory response to lipopolysaccharide (LPS) or endotoxin released from bacteria. LPS is a major constituent of the outer membrane of Gram-negative bacteria, and its terminal disaccharide phospholipid (lipid A) portion contains the key structural features responsible for toxic activity. Based on the proposed structure of nontoxic Rhodobacter capsulatus lipid A, a fully stabilized endotoxin antagonist E5531 has been synthesized. In vitro, E5531 demonstrated potent antagonism of LPS-mediated cellular activation in a variety of systems. In vivo, E5531 protected mice from LPS-induced lethality and, in cooperation with an antibiotic, protected mice from a lethal infection of viable Escherichia coli.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Stuehr, D. J., & Nathan, C. F. (1989) · The Journal of Experimental Medicine · doi:10.1084/jem.169.5.1543 · Cited by 1,744
Pathogenetic Mechanisms of Septic Shock
Epstein, F. H., & Parrillo, J. E. (1993) · New England Journal of Medicine · doi:10.1056/nejm199305203282008 · Cited by 1,548
Synthetic and natural Escherichia coli free lipid A express identical endotoxic activities
GALANOS, C., LÜDERITZ, O., RIETSCHEL, E. T., WESTPHAL, O., BRADE, H., BRADE, L., FREUDENBERG, M., SCHADE, U., IMOTO, M., YOSHIMURA, H., et al. (1985) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1985.tb08798.x · Cited by 491
Gram-negative sepsis: a dilemma of modern medicine
Bone, R. C. (1993) · Clinical Microbiology Reviews · doi:10.1128/cmr.6.1.57 · Cited by 208
Endotoxin, septic shock and acute lung injury: Neutrophils, macrophages and inflammatory mediators
Welbourn, C. R. B., & Young, Y. (1992) · Journal of British Surgery · doi:10.1002/bjs.1800791006 · Cited by 197
Bone, R. C. (1991) · Chest · doi:10.1378/chest.100.3.802 · Cited by 193
BILLIAU, A., & VANDEKERCKHOVE, F. (1991) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1991.tb01410.x · Cited by 184
A Quantitative Bioassay for HIV-1 Based on Trans-Activation
Felber, B. K., & Pavlakis, G. N. (1988) · Science · doi:10.1126/science.3422113 · Cited by 176
Loppnow, H., Libby, P., Freudenberg, M., Krauss, J. H., Weckesser, J., & Mayer, H. (1990) · Infection and Immunity · doi:10.1128/iai.58.11.3743-3750.1990 · Cited by 163
Takayama, K., Qureshi, N., Beutler, B., & Kirkland, T. N. (1989) · Infection and Immunity · doi:10.1128/iai.57.4.1336-1338.1989 · Cited by 151
Cited by
Raetz, C. R. H., & Whitfield, C. (2002) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.71.110601.135414 · Cited by 4,404
Toll-like Receptor-4 Mediates Lipopolysaccharide-induced Signal Transduction
Chow, J. C., Young, D. W., Golenbock, D. T., Christ, W. J., & Gusovsky, F. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.16.10689 · Cited by 1,924
Self-citationLipid A Modification Systems in Gram-Negative Bacteria
Raetz, C. R. H., Reynolds, C. M., Trent, M. S., & Bishop, R. E. (2007) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.76.010307.145803 · Cited by 1,340
Structure and Function of Toll Receptors and Their Ligands
Gay, N. J., & Gangloff, M. (2007) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.76.060305.151318 · Cited by 667
Fujihara, M., Muroi, M., Tanamoto, K.-I., Suzuki, T., Azuma, H., & Ikeda, H. (2003) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2003.08.003 · Cited by 574
Toll–Like Receptor 4 Is Involved in the Mechanism of Early Alcohol–Induced Liver Injury in Mice
Uesugi, T., Froh, M., Arteel, G. E., Bradford, B. U., & Thurman, R. G. (2001) · Hepatology · doi:10.1053/jhep.2001.25350 · Cited by 488
Rietschel, E. T., Brade, H., Holst, O., Brade, L., Müller-Loennies, S., Mamat, U., Zähringer, U., Beckmann, F., Seydel, U., Brandenburg, K., et al. (1996) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-642-80186-0_3 · Cited by 469
Therapeutic Targeting of Toll-Like Receptors for Infectious and Inflammatory Diseases and Cancer
O’Neill, L. A. J., Bryant, C. E., & Doyle, S. L. (2009) · Pharmacological Reviews · doi:10.1124/pr.109.001073 · Cited by 427
Henderson, B., Poole, S., & Wilson, M. (1996) · Microbiological Reviews · doi:10.1128/mmbr.60.2.316-341.1996 · Cited by 419
Pfeiffer, A., Böttcher, A., Orsó, E., Kapinsky, M., Nagy, P., Bodnár, A., Spreitzer, I., Liebisch, G., Drobnik, W., Gempel, K., et al. (2001) · European Journal of Immunology · doi:10.1002/1521-4141(200111)31:11<3153::aid-immu3153>3.0.co;2-0 · Cited by 401
The molecular basis of the host response to lipopolysaccharide
Bryant, C. E., Spring, D. R., Gangloff, M., & Gay, N. J. (2010) · Nature Reviews Microbiology · doi:10.1038/nrmicro2266 · Cited by 391
Lipopolysaccharide Interaction with Cell Surface Toll-like Receptor 4-MD-2
Akashi, S., Saitoh, S.-I., Wakabayashi, Y., Kikuchi, T., Takamura, N., Nagai, Y., Kusumoto, Y., Fukase, K., Kusumoto, S., Adachi, Y., et al. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20031076 · Cited by 385
ACUTE RESPIRATORY DISTRESS SYNDROME
Conner, B. D., & Bernard, G. R. (2000) · Clinics in Chest Medicine · doi:10.1016/s0272-5231(05)70167-2 · Cited by 382
Ii, M., Matsunaga, N., Hazeki, K., Nakamura, K., Takashima, K., Seya, T., Hazeki, O., Kitazaki, T., & Iizawa, Y. (2006) · Molecular Pharmacology · doi:10.1124/mol.105.019695 · Cited by 377
Protective role of phospholipid oxidation products in endotoxin-induced tissue damage
Bochkov, V. N., Kadl, A., Huber, J., Gruber, F., Binder, B. R., & Leitinger, N. (2002) · Nature · doi:10.1038/nature01023 · Cited by 367
Kawasaki, K., Akashi, S., Shimazu, R., Yoshida, T., Miyake, K., & Nishijima, M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.4.2251 · Cited by 355
Gao, W., Xiong, Y., Li, Q., & Yang, H. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00508 · Cited by 353
Cooke, K. R., Hill, G. R., Crawford, J. M., Bungard, D., Brinson, Y. S., Delmonte, J., & Ferrara, J. L. (1998) · Journal of Clinical Investigation · doi:10.1172/jci4285 · Cited by 335
Lai, H.-C., Lin, T.-L., Chen, T.-W., Kuo, Y.-L., Chang, C.-J., Wu, T.-R., Shu, C.-C., Tsai, Y.-H., Swift, S., & Lu, C.-C. (2022) · Gut · doi:10.1136/gutjnl-2020-322599 · Cited by 331
Solution structure and dynamics of the outer membrane enzyme PagP by NMR
Hwang, P. M., Choy, W.-Y., Lo, E. I., Chen, L., Forman-Kay, J. D., Raetz, C. R. H., Privé, G. G., Bishop, R. E., & Kay, L. E. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.212344499 · Cited by 329
Biological activities of lipopolysaccharides are determined by the shape of their lipid A portion
Schromm, A. B., Brandenburg, K., Loppnow, H., Moran, A. P., Koch, M. H. J., Rietschel, E. T., & Seydel, U. (2000) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2000.01204.x · Cited by 319
Molecular mechanisms of endotoxin activity
Schletter, J., Heine, H., Ulmer, A. J., & Rietschel, E. T. (1995) · Archives of Microbiology · doi:10.1007/bf02529735 · Cited by 308
Mullarkey, M., Rose, J. R., Bristol, J., Kawata, T., Kimura, A., Kobayashi, S., Przetak, M., Chow, J., Gusovsky, F., Christ, W. J., et al. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.044487 · Cited by 292
Self-citationCooke, K. R., Gerbitz, A., Crawford, J. M., Teshima, T., Hill, G. R., Tesolin, A., Rossignol, D. P., & Ferrara, J. L. M. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12156 · Cited by 291
Self-citationA novel Escherichia coli lipid A mutant that produces an antiinflammatory lipopolysaccharide.
Somerville, J. E., Cassiano, L., Bainbridge, B., Cunningham, M. D., & Darveau, R. P. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118423 · Cited by 275
Means, T. K., Jones, B. W., Schromm, A. B., Shurtleff, B. A., Smith, J. A., Keane, J., Golenbock, D. T., Vogel, S. N., & Fenton, M. J. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.6.4074 · Cited by 270
The biology of Toll-like receptors
Means, T. K., Golenbock, D. T., & Fenton, M. J. (2000) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(00)00006-x · Cited by 267
Such stuff as dreams are made on: mediator-directed therapy in sepsis
Marshall, J. C. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1084 · Cited by 264
Savva, A., & Roger, T. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00387 · Cited by 261
McAdam, B. F., Mardini, I. A., Habib, A., Burke, A., Lawson, J. A., Kapoor, S., & FitzGerald, G. A. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9523 · Cited by 253
Structural requirements for TLR4-mediated LPS signalling: a biological role for LPS modifications
Bäckhed, F., Normark, S., Schweda, E. K. H., Oscarson, S., & Richter-Dahlfors, A. (2003) · Microbes and Infection · doi:10.1016/s1286-4579(03)00207-7 · Cited by 177
Uchiyama, A., Kim, J.-S., Kon, K., Jaeschke, H., Ikejima, K., Watanabe, S., & Lemasters, J. J. (2008) · Hepatology · doi:10.1002/hep.22498 · Cited by 154
Lin, T.-L., Shu, C.-C., Chen, Y.-M., Lu, J.-J., Wu, T.-S., Lai, W.-F., Tzeng, C.-M., Lai, H.-C., & Lu, C.-C. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00554 · Cited by 143
Sprong, T., Ley, P. V. D., Abdollahi-Roodsaz, S., Joosten, L., Meer, J. V. D., Netea, M., & Deuren, M. V. (2011) · Innate Immunity · doi:10.1177/1753425910383999 · Cited by 20
Metadata
- Authors
- Christ, W. J., Asano, O., Robidoux, A. L. C., Perez, M., Wang, Y., Dubuc, G. R., Gavin, W. E., Hawkins, L. D., McGuinness, P. D., Mullarkey, M. A., Lewis, M. D., Kishi, Y., Kawata, T., Bristol, J. R., Rose, J. R., Rossignol, D. P., Kobayashi, S., Hishinuma, L., Kimura, A., Asakawa, N., Katayama, K., & Yamatsu, L.
- Venue
- Science
- Published
- 1995-04-07
- Volume
- 268
- Issue
- 5207
- Pages
- 80-83
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2008077535
- Cited by
- 318
- References
- 21
- FWCI
- 7.62
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.